Search Results

PFK-015 25 mg  | 99.70%

TargetMol

PFK-015 (PFK15) is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).

More Information Supplier Page

PFK-015 50 mg  | 99.70%

TargetMol

PFK-015 (PFK15) is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).

More Information Supplier Page

PFK-015 5 mg  | 99.70%

TargetMol

PFK-015 (PFK15) is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).

More Information Supplier Page

Latanoprost 10 mg  | Purity Not Available

TargetMol

Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.

More Information Supplier Page

Latanoprost 50 mg  | Purity Not Available

TargetMol

Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.

More Information Supplier Page

Latanoprost 5 mg  | Purity Not Available

TargetMol

Latanoprost is a prostaglandin F2alpha analogue and a prostanoid selective FP receptor agonist with an ocular hypertensive effect.

More Information Supplier Page

Tolmetin 100 mg  | Purity Not Available

TargetMol

Tolmetin is a Nonsteroidal Anti-inflammatory Drug. The mechanism of action of tolmetin is as a Cyclooxygenase Inhibitor. The chemical classification of tolmetin is Nonsteroidal Anti-inflammatory Compounds.

More Information Supplier Page

Dolutegravir sodium 5 mg  | 99.74%

TargetMol

Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

More Information Supplier Page

Dolutegravir sodium 50 mg  | 99.74%

TargetMol

Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

More Information Supplier Page

Dolutegravir sodium 2 mg  | 99.74%

TargetMol

Dolutegravir sodium salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G140S/Q148H.

More Information Supplier Page